Melting point	160-161 ºC***
Boiling point	272 ºC****
Flash point	78.9±0.0 ºC, 计算值*
Density	1.5 g/cm3**

没有数据	没有数据

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

More

Name	CAS

More

Articles

Peer-Reviewed Papers

Bevacizumab improves splenomegaly and decreases production of hyaluronic acid after L-OHP based chemotherapy.Yusuke Arakawa et al.Anticancer research, 34(4), 1953-1958 (2014-04-03) Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2.De-Shen Wang et al.Oncotarget, 5(12), 4529-4542 (2014-07-02) Splenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndrome.K Imai et al.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 40(5), 559-566 (2014-01-07) Anti-proliferative and cytoskeleton-disruptive effects of icariin on HepG2 cells.Zhi-Min Wang et al.Molecular medicine reports, 12(5), 6815-6820 (2015-09-04) Huaier Augmented the Chemotherapeutic Sensitivity of Oxaliplatin via Downregulation of YAP in Hepatocellular Carcinoma.Yuquan Tao et al.Journal of Cancer, 9(21), 3962-3970 (2018-11-10) The contribution of Gi/o protein to opioid antinociception in an oxaliplatin-induced neuropathy rat model.Tomoe Kanbara et al.Journal of pharmacological sciences, 126(3), 264-273 (2014-10-28) siRNA-mediated silencing of MDR1 reverses the resistance to oxaliplatin in SW480/OxR colon cancer cells.N Montazami et al.Cellular and molecular biology (Noisy-le-Grand, France), 61(2), 98-103 (2015-05-31) Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer.Ching-Wei Chang et al.International journal of molecular sciences, 21(2) (2020-01-16) The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.Arancha Prada-Villaverde et al.Journal of surgical oncology, 110(7), 779-785 (2014-08-05) A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors.Syma Iqbal et al.Cancer chemotherapy and pharmacology, 72(1), 85-91 (2013-05-29) The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer.D Khayat et al.Oncology (Williston Park, N.Y.), 15(4), 415-429 (2001-05-12) Maintenance therapy for colorectal cancer.John L Marshall Oncology (Williston Park, N.Y.), 28(4), 322-322 (2014-05-21) Oxaliplatin enhances gap junction-mediated coupling in cell cultures of mouse trigeminal ganglia.Jeppe Nørgaard Poulsen et al.Experimental cell research, 336(1), 94-99 (2015-05-23) Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH study.Shukui Qin et al.The oncologist, 19(11), 1169-1178 (2014-09-17) Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis?Khaled M Madbouly et al.Diseases of the colon and rectum, 56(5), 577-585 (2013-04-12) Morphine and oxycodone, but not fentanyl, exhibit antinociceptive effects mediated by G-protein inwardly rectifying potassium (GIRK) channels in an oxaliplatin-induced neuropathy rat model.Tomoe Kanbara et al.Neuroscience letters, 580, 119-124 (2014-08-17) Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models.Giovanna Bianchi et al.Oncotarget, 6(14), 11806-11819 (2015-04-25) Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.Terence C Chua et al.Journal of surgical oncology, 108(2), 81-88 (2013-06-06) Oxaliplatin-induced hepatocellular injury and ototoxicity: a review of the literature and report of unusual side effects of a commonly used chemotherapeutic agent.Nicole O Vietor et al.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 18(3), 355-359 (2012-02-16) Apoptotic Effect of Extract from Medicinal Mushroom from Taiwan Taiwanofungus salmoneus (Higher Basidiomycetes) Mycelium Combined with or without Cisplatin on Hepatocellular Carcinoma Cells.Rao-Chi Chien et al.International journal of medicinal mushrooms, 17(6), 567-577 (2015-09-10) Oxaliplatin-induced lung toxicity. Case report and review of the literature.Tiziana Prochilo et al.Current drug safety, 7(2), 179-182 (2012-08-10) A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer.Young Saing Kim et al.Cancer chemotherapy and pharmacology, 73(1), 163-169 (2013-11-10) A pragmatic definition of therapeutic synergy suitable for clinically relevant in vitro multicompound analyses.Muhammad Kashif et al.Molecular cancer therapeutics, 13(7), 1964-1976 (2014-04-24) Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer.Davendra P S Sohal et al.Cancer chemotherapy and pharmacology, 71(6), 1485-1491 (2013-03-28) Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer.Lucía Cortejoso et al.Cancer chemotherapy and pharmacology, 71(6), 1463-1472 (2013-04-02) Oxaliplatin as a radiosensitiser for upper and lower gastrointestinal tract malignancies: what have we learned from a decade of translational research?Esme J Hill et al.Critical reviews in oncology/hematology, 83(3), 353-387 (2012-02-09) Oxaliplatin-induced thrombotic thrombocytopenic purpura: case report and literature review.Jiaxin Niu et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30(31), e312-e314 (2012-09-19) Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics.Stefan Vallo et al.Translational oncology, 8(3), 210-216 (2015-06-10) Current strategies to minimize toxicity of oxaliplatin: selection of pharmacogenomic panel tests.Raffaele Di Francia et al.Anti-cancer drugs, 24(10), 1069-1078 (2013-09-13) Milnacipran inhibits oxaliplatin-induced mechanical allodynia through spinal action in mice.Tsugunobu Andoh et al.Biological & pharmaceutical bulletin, 38(1), 151-154 (2015-03-07) FOLFIRI + bevacizumab as second-line therapy for metastatic colorectal cancer pretreated with oxaliplatin: a pooled analysis of published trials.Giordano Domenico Beretta et al.Medical oncology (Northwood, London, England), 30(1), 486-486 (2013-02-13) C-reactive protein is a negative independent factor in patients with stage IV colorectal cancer undergoing oxaliplatin-based chemotherapy.Minoru Fukuchi et al.Anticancer research, 33(11), 5051-5055 (2013-11-14) Atonal homolog 1 protein stabilized by tumor necrosis factor α induces high malignant potential in colon cancer cell line.Keita Fukushima et al.Cancer science, 106(8), 1000-1007 (2015-05-29) EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells.H I Onen et al.Human & experimental toxicology, 34(2), 117-126 (2014-07-17) High-throughput RNAi screening of human kinases identifies predictors of clinical outcome in colorectal cancer patients treated with oxaliplatin.Moubin Lin et al.Oncotarget, 6(18), 16774-16785 (2015-04-24) miR-219-5p plays a tumor suppressive role in colon cancer by targeting oncogene Sall4.Ji Cheng et al.Oncology reports, 34(4), 1923-1932 (2015-08-05) Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death.K Moriwaki et al.Cell death & disease, 6, e1636-e1636 (2015-02-13) IFN-γ selectively exerts pro-apoptotic effects on tumor-initiating label-retaining colon cancer cells.Chao Ni et al.Cancer letters, 336(1), 174-184 (2013-05-07) miR-124 Intensified Oxaliplatin-Based Chemotherapy by Targeting CAPN2 in Colorectal Cancer.Xu-Qin Xie et al.Molecular therapy oncolytics, 17, 320-331 (2020-05-10) The role of Her2-Nrf2 axis in induction of oxaliplatin resistance in colon cancer cells.Abbas Pirpour Tazehkand et al.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 103, 755-766 (2018-04-24) Randomized, placebo-controlled trial of K1 acupoint acustimulation to prevent cisplatin-induced or oxaliplatin-induced nausea.Yehua Shen et al.Cancer, 121(1), 84-92 (2014-09-11) VGluT3⁺ primary afferents play distinct roles in mechanical and cold hypersensitivity depending on pain etiology.Peter Draxler et al.The Journal of neuroscience : the official journal of the Society for Neuroscience, 34(36), 12015-12028 (2014-09-05) Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin.Ya-Jie Zhang et al.World journal of gastroenterology, 20(25), 8229-8236 (2014-07-11) Sensitization of mesothelioma cells to platinum-based chemotherapy by GSTπ knockdown.Jianli Chen et al.Biochemical and biophysical research communications, 447(1), 77-82 (2014-04-03) Oxaliplatin-related thrombocytopenia.D L Jardim et al.Annals of oncology : official journal of the European Society for Medical Oncology, 23(8), 1937-1942 (2012-04-27) Gc-protein-derived macrophage activating factor counteracts the neuronal damage induced by oxaliplatin.Gabriele Morucci et al.Anti-cancer drugs, 26(2), 197-209 (2014-10-12) Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma.Hui Wang et al.Cancer, 121(17), 2917-2925 (2015-06-03) Complete remission of recurrent and refractory ovarian cancers using weekly administration of bevacizumab and gemcitabine/oxaliplatin: report of two cases.M Takano et al.European journal of gynaecological oncology, 34(1), 90-93 (2013-04-18) [A case of bleeding stomal varices during the course of oxaliplatin-based chemotherapy for recurrent rectal cancer].Naruyuki Kobayashi et al.Gan to kagaku ryoho. Cancer & chemotherapy, 41(7), 905-907 (2014-08-19) [Preventive trial of preheating administration of oxaliplatin-diluted solution in combination with a hot compress for oxaliplatin-induced venous pain].Risa Miyajima et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(4), 537-540 (2013-07-16) Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.Tingting Hu et al.PloS one, 10(5), e0125281-e0125281 (2015-05-02) Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma.Pauline Duconseil et al.The American journal of pathology, 185(4), 1022-1032 (2015-03-15) Analgesic Effects of Bee Venom Derived Phospholipase A(2) in a Mouse Model of Oxaliplatin-Induced Neuropathic Pain.Dongxing Li et al.Toxins, 7(7), 2422-2434 (2015-07-02) Defective mismatch repair and benefit from bevacizumab for colon cancer: findings from NSABP C-08.Kay Pogue-Geile et al.Journal of the National Cancer Institute, 105(13), 989-992 (2013-07-04) Nicotinic Acetylcholine Receptors Mediate the Suppressive Effect of an Injection of Diluted Bee Venom into the GV3 Acupoint on Oxaliplatin-Induced Neuropathic Cold Allodynia in Rats.Heera Yoon et al.Biological & pharmaceutical bulletin, 38(5), 710-714 (2015-03-11) Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community.Dolly C Penn et al.Cancer, 121(1), 93-101 (2014-09-12) Effects of the compounds resveratrol, rutin, quercetin, and quercetin nanoemulsion on oxaliplatin-induced hepatotoxicity and neurotoxicity in mice.Tania E Schwingel et al.Naunyn-Schmiedeberg's archives of pharmacology, 387(9), 837-848 (2014-06-09) Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells--A Key Role for Heat-Shock Protein 70 and Receptor CD91.Josephine Salimu et al.Cancer immunology research, 3(6), 678-688 (2015-02-14) Effect of the norepinephrine transporter (NET) inhibition on μ-opioid receptor (MOR)-induced anti-nociception in a bone cancer pain model.Hiroko Ono et al.Journal of pharmacological sciences, 125(3), 264-273 (2014-06-27) [Basic evidence for efficacy of Goshajinkigan on oxaliplatin-induced neuropathy].Soichiro Ushio et al.Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 143(3), 126-130 (2014-03-13) Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models.Giovanna Bianchi et al.Oncotarget, 6(14), 11806-11819 (2015-04-25) Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.Terence C Chua et al.Journal of surgical oncology, 108(2), 81-88 (2013-06-06) Oxaliplatin-induced hepatocellular injury and ototoxicity: a review of the literature and report of unusual side effects of a commonly used chemotherapeutic agent.Nicole O Vietor et al.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 18(3), 355-359 (2012-02-16) Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH study.Shukui Qin et al.The oncologist, 19(11), 1169-1178 (2014-09-17) Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin.Ya-Jie Zhang et al.World journal of gastroenterology, 20(25), 8229-8236 (2014-07-11) [A case of recurrent rectal cancer successfully treated for a long period with capecitabine plus oxaliplatin and bevacizumab therapy].Noriko Iwata et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(12), 2008-2010 (2014-01-08) Identification of long-range epigenetic silencing on chromosome 15q25 and its clinical implication in gastric cancer.Jee-Youn Kang et al.The American journal of pathology, 185(3), 666-678 (2015-01-13) Incidence of cold-induced peripheral neuropathy and dose modification of adjuvant oxaliplatin-based chemotherapy for patients with colorectal cancer.Rahim Altaf et al.Oncology, 87(3), 167-172 (2014-07-12) Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.Yuan-Hong Gao et al.Journal of surgical oncology, 109(5), 478-482 (2013-11-30) Intraductal Radiofrequency Ablation Followed by Locoregional Tumor Treatments for Treating Occluded Biliary Stents in Non-Resectable Malignant Biliary Obstruction: A Single-Institution Experience.Xu-Hua Duan et al.PloS one, 10(8), e0134857-e0134857 (2015-08-06) Posterior reversible encephalopathy syndrome following chemotherapy with oxaliplatin and a fluoropyrimidine: a case report and literature review.Giuseppe Femia et al.Asia-Pacific journal of clinical oncology, 8(2), 115-122 (2012-04-25) Hyperphosphorylation of PP2A in colorectal cancer and the potential therapeutic value showed by its forskolin-induced dephosphorylation and activation.Cristobal I, Rincon R, Manso R, et al. Biochimica et Biophysica Acta, 1842(9), 1823-1829 (2014) miR-219-5p plays a tumor suppressive role in colon cancer by targeting oncogene Sall4.Ji Cheng et al.Oncology reports, 34(4), 1923-1932 (2015-08-05) Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis?Khaled M Madbouly et al.Diseases of the colon and rectum, 56(5), 577-585 (2013-04-12) Oxaliplatin-induced lung toxicity. Case report and review of the literature.Tiziana Prochilo et al.Current drug safety, 7(2), 179-182 (2012-08-10) A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer.Young Saing Kim et al.Cancer chemotherapy and pharmacology, 73(1), 163-169 (2013-11-10) [A case of metastatic acsending colon cancer showing sustained complete response to chemotherapy with SOX and followed UFT].Tomoaki Yoh et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(7), 947-949 (2013-07-19) Oxaliplatin-based chemotherapy in patients aged 75 years or older with metastatic colorectal cancer.Minoru Fukuchi et al.Anticancer research, 33(10), 4627-4630 (2013-10-15) Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma.Pauline Duconseil et al.The American journal of pathology, 185(4), 1022-1032 (2015-03-15) Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).O Katopodis et al.Cancer chemotherapy and pharmacology, 74(2), 333-340 (2014-06-16) Virchow lymph node metastatic recurrence of sigmoid colon cancer with severe lymph node metastases successfully treated using systemic chemotherapy combined with radiotherapy.Takafumi Ohchi et al.Anticancer research, 33(7), 2935-2940 (2013-06-20) Metformin revert insulin-induced oxaliplatin resistance by activating mitochondrial apoptosis pathway in human colon cancer HCT116 cells.Chao Liu et al.Cancer medicine, 9(11), 3875-3884 (2020-04-06) FOLFIRINOX bevacizumab is a promising therapy for chemorefractory metastatic colorectal cancer.Marie Chaix et al.Oncology, 87(3), 148-158 (2014-07-12) Analgesic Effects of Bee Venom Derived Phospholipase A(2) in a Mouse Model of Oxaliplatin-Induced Neuropathic Pain.Dongxing Li et al.Toxins, 7(7), 2422-2434 (2015-07-02) GTP depletion synergizes the anti-proliferative activity of chemotherapeutic agents in a cell type-dependent mannerLin T, et al. Biochemical and Biophysical Research Communications, 414(2), 403-408 (2011) Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients.Roser Velasco et al.Journal of neurology, neurosurgery, and psychiatry, 85(4), 392-398 (2013-07-03) [IV. Is oxaliplatin effective as adjuvant chemotherapy for stage III rectum cancer post operation?].Mitsuhito Sasaki et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(11), 1469-1 74 (2013-12-21) [Preventive trial of preheating administration of oxaliplatin-diluted solution in combination with a hot compress for oxaliplatin-induced venous pain].Risa Miyajima et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(4), 537-540 (2013-07-16) Defective mismatch repair and benefit from bevacizumab for colon cancer: findings from NSABP C-08.Kay Pogue-Geile et al.Journal of the National Cancer Institute, 105(13), 989-992 (2013-07-04) IFN-γ selectively exerts pro-apoptotic effects on tumor-initiating label-retaining colon cancer cells.Chao Ni et al.Cancer letters, 336(1), 174-184 (2013-05-07) Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?Xiao Lyu et al.Journal of surgical oncology, 110(7), 864-868 (2014-07-01) Bioreactor-engineered cancer tissue-like structures mimic phenotypes, gene expression profiles and drug resistance patterns observed "in vivo".Christian Hirt et al.Biomaterials, 62, 138-146 (2015-06-09) Adjuvant chemoradiation plus intraoperative radiotherapy versus adjuvant chemoradiation alone in patients with locally advanced rectal cancer.Qing Zhang et al.American journal of clinical oncology, 38(1), 11-16 (2015-01-24) Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in rats.Toru Kono et al.Scientific reports, 5, 16078-16078 (2015-11-07) Monofunctional platinum(II) complexes with potent tumor cell growth inhibitory activity: the effect of a hydrogen-bond donor/acceptor N-heterocyclic ligand.Nicola Margiotta et al.ChemMedChem, 9(6), 1161-1168 (2014-05-07) Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment.Marloes Zoetemelk et al.Molecules (Basel, Switzerland), 25(11) (2020-06-10) XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis.Fanghui Ye et al.Cancer chemotherapy and pharmacology, 71(3), 733-740 (2013-01-10) [Three cases of fatal thrombocytopenia after oxaliplatin-based chemotherapy].Hiroki Osumi et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(11), 1557-1560 (2013-11-16) Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer.Tetsuro Ikeya et al.Journal of cancer research and clinical oncology, 141(2), 307-313 (2014-08-16) Oxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissueJamieson SMF, et al. Molecular Pain, 5(1), 66-66 (2009) Intravenous glutamine appears to reduce the severity of symptomatic platinum-induced neuropathy: a prospective randomized study.Jen-Seng Huang et al.Journal of chemotherapy (Florence, Italy), 27(4), 235-240 (2015-03-25) Establishment of opioid-induced rewarding effects under oxaliplatin- and Paclitaxel-induced neuropathy in rats.Tomohisa Mori et al.Journal of pharmacological sciences, 126(1), 47-55 (2014-08-22) Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial.Alexander Stein et al.BMC cancer, 15, 564-564 (2015-08-01) Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients.Juan Antonio Cruzado et al.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 22(7), 1815-1823 (2014-02-19) Physician behavior impact when revenue shifted from drugs to services.Bruce Feinberg et al.The American journal of managed care, 20(4), 303-310 (2014-06-03) Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.Tingting Hu et al.PloS one, 10(5), e0125281-e0125281 (2015-05-02) Transient receptor potential ankyrin 1 that is induced in dorsal root ganglion neurons contributes to acute cold hypersensitivity after oxaliplatin administration.Ken Yamamoto et al.Molecular pain, 11, 69-69 (2015-11-15) Pharmacogenomics panel test for prevention toxicity in patient who receive Fluoropirimidine/Oxaliplatin-based therapy.R Di Francia et al.European review for medical and pharmacological sciences, 16(9), 1211-1217 (2012-10-11) In vitro and in vivo enhancement of chemoradiation using the oral PARP inhibitor ABT-888 in colorectal cancer cells.Joseph W Shelton et al.International journal of radiation oncology, biology, physics, 86(3), 469-476 (2013-04-02) Widespread pain reliever profile of a flower extract of Tanacetum parthenium.Lorenzo Di Cesare Mannelli et al.Phytomedicine : international journal of phytotherapy and phytopharmacology, 22(7-8), 752-758 (2015-07-05) Cisplatin, oxaliplatin, and carboplatin unequally inhibit in vitro mRNA translation.Jonas Philipp Becker et al.Toxicology letters, 225(1), 43-47 (2013-11-28) MiR-5000-3p, miR-5009-3P and miR-552: potential microRNA biomarkers of side population cells in colon cancer.Zhong-Sheng Xia et al.Oncology reports, 32(2), 589-596 (2014-06-06) A role for Myh1 in DNA repair after treatment with strand-breaking and crosslinking chemotherapeutic agents.Kristina Jansson et al.Environmental and molecular mutagenesis, 54(5), 327-337 (2013-05-17) Establishment and characterization of SUIT-58 pancreas cancer cell line and its subline S58-SF adapted to serum-free condition derived from metastatic liver tumor.Nobuyasu Takahashi et al.Human cell, 28(4), 190-198 (2015-07-05) A surface wipe sampling and LC-MS/MS method for the simultaneous detection of six antineoplastic drugs commonly handled by healthcare workers.Matthew Jeronimo et al.Analytical and bioanalytical chemistry, 407(23), 7083-7092 (2015-07-05) Gabapentin prevents oxaliplatin-induced central sensitization in the dorsal horn neurons in rats.Teng Ruyang et al.Iranian journal of basic medical sciences, 18(5), 493-498 (2015-07-01) Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells.Min Shi et al.Cancer chemotherapy and pharmacology, 72(1), 35-44 (2013-05-29) Effect of combined treatment with the epirubicin-incorporating micelles (NC-6300) and 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016) on a human gastric cancer model.Yoshiyuki Yamamoto et al.International journal of cancer, 135(1), 214-223 (2013-12-20) [Recurrent rectal cancer with multiple liver and lung metastases treated effectively with oxaliplatin and capecitabine plus bevacizumab chemotherapy-a case report].Nobushige Yabe et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(12), 1834-1836 (2014-01-08) Analgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin.Jennifer R Deuis et al.Neuro-oncology, 16(10), 1324-1332 (2014-04-10) Hyperthermic intraperitoneal chemotherapy using a combination of mitomycin C,5-fluorouracil, and oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study.T Shimizu et al.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 40(5), 521-528 (2014-01-07) Cisplatin, oxaliplatin, and carboplatin unequally inhibit in vitro mRNA translation.Jonas Philipp Becker et al.Toxicology letters, 225(1), 43-47 (2013-11-28) [Evaluation of usability of an anticancer drug after changing it to liquid formulation].Kumi Nakamura et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(3), 337-341 (2013-03-20) Interleukin 22 protects colorectal cancer cells from chemotherapy by activating the STAT3 pathway and inducing autocrine expression of interleukin 8.Tingyu Wu et al.Clinical immunology (Orlando, Fla.), 154(2), 116-126 (2014-07-27) FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.Ningning Li et al.Oncotarget, 6(11), 9240-9256 (2015-04-11) Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial.Alexander Stein et al.BMC cancer, 15, 564-564 (2015-08-01) Response to chemotherapy in metastatic colorectal cancer after exposure to oxaliplatin in the adjuvant setting.Louis-Charles Moreau et al.Anticancer research, 33(4), 1765-1768 (2013-04-09) NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.Somnath Mukherjee et al.BMC cancer, 15, 48-48 (2015-04-17) [A case of primary duodenal cancer recurrence successfully treated with CapeOX therapy].Masatake Miyamoto et al.Gan to kagaku ryoho. Cancer & chemotherapy, 41(4), 495-498 (2014-04-20) Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapy.Bo Hultman et al.Journal of experimental & clinical cancer research : CR, 33, 110-110 (2014-12-22) A role for Myh1 in DNA repair after treatment with strand-breaking and crosslinking chemotherapeutic agents.Kristina Jansson et al.Environmental and molecular mutagenesis, 54(5), 327-337 (2013-05-17) Establishment and characterization of SUIT-58 pancreas cancer cell line and its subline S58-SF adapted to serum-free condition derived from metastatic liver tumor.Nobuyasu Takahashi et al.Human cell, 28(4), 190-198 (2015-07-05) Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors.Xiaodong Zhu et al.Journal of cancer research and clinical oncology, 141(1), 109-118 (2014-07-19) Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST.Ming Liu et al.European radiology, 25(8), 2502-2511 (2015-02-24) Trifluridine Induces p53-Dependent Sustained G2 Phase Arrest with Its Massive Misincorporation into DNA and Few DNA Strand Breaks.Kazuaki Matsuoka et al.Molecular cancer therapeutics, 14(4), 1004-1013 (2015-02-24) Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.Yasuhide Yamada et al.The Lancet. Oncology, 14(13), 1278-1286 (2013-11-15) Regorafenib (BAY 73-4506): antitumor and antimetastatic activities in preclinical models of colorectal cancer.Roberta Schmieder et al.International journal of cancer, 135(6), 1487-1496 (2013-12-19) Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial.Tom Waddell et al.The Lancet. Oncology, 14(6), 481-489 (2013-04-19) Ursodeoxycholic acid effectively kills drug-resistant gastric cancer cells through induction of autophagic death.Sung-Chul Lim et al.Oncology reports, 34(3), 1261-1268 (2015-07-03) Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma.Pablo E Serrano et al.International journal of radiation oncology, biology, physics, 90(2), 270-277 (2014-08-12) Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.Hans-Joachim Schmoll et al.The Lancet. Oncology, 15(13), 1481-1492 (2014-12-03) Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11.Anna Zagryazhskaya et al.Oncotarget, 6(14), 12156-12173 (2015-05-06) Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma.Maria Inés Molejon et al.Oncotarget, 6(10), 7408-7423 (2015-03-24) A shotgun approach for the identification of platinum-protein complexes.Irene Moraleja et al.Analytical and bioanalytical chemistry, 407(9), 2393-2403 (2015-01-27) HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway.Weijun Liu et al.Cancer biology & therapy, 16(4), 511-517 (2015-03-18) Reversible bilateral blepharoptosis following oxaliplatin infusion: a case report and literature review.Giuseppe Fanetti et al.Tumori, 99(5), e216-e219 (2014-02-08) Goshajinkigan, a traditional Japanese medicine, prevents oxaliplatin-induced acute peripheral neuropathy by suppressing functional alteration of TRP channels in rat.Keita Mizuno et al.Journal of pharmacological sciences, 125(1), 91-98 (2014-05-03) RNA-seq identifies determinants of oxaliplatin sensitivity in colorectal cancer cell lines.Xin-Xiang Li et al.International journal of clinical and experimental pathology, 7(7), 3763-3770 (2014-08-15) A pharmacokinetic binding model for bevacizumab and VEGF165 in colorectal cancer patients.Eirini Panoilia et al.Cancer chemotherapy and pharmacology, 75(4), 791-803 (2015-02-18) Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo.Szu-Jung Chen et al.Biochemical pharmacology, 95(1), 28-37 (2015-03-25) Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.Bernard Nordlinger et al.The Lancet. Oncology, 14(12), 1208-1215 (2013-10-15) Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins.Sayo Horibe et al.Life sciences, 124, 31-40 (2015-01-28) Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival.M Bickeböller et al.Oncogene, 34(9), 1150-1159 (2014-03-26) Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis.Maude Gabriel et al.BMC cancer, 15, 227-227 (2015-04-18) Sequential chemotherapies for advanced gastric cancer: a retrospective analysis of 111 patients.Christoph Elsing et al.Oncology, 85(5), 262-268 (2013-11-07) Inflammatory and neuropathic pain are rapidly suppressed by peripheral block of hyperpolarisation-activated cyclic nucleotide-gated ion channels.Gareth T Young et al.Pain, 155(9), 1708-1719 (2014-05-28) The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study.D Hompes et al.Journal of surgical oncology, 109(6), 527-532 (2014-01-01) IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance.Xiao-Lei Ye et al.Oncology reports, 33(6), 2746-2752 (2015-04-08) Colorectal cancer: using blood samples and tumor tissue to detect K-ras mutations.Yang Li et al.Expert review of anticancer therapy, 15(6), 715-725 (2015-06-04) HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy.Ganji Purnachandra Nagaraju et al.Oncotarget, 5(20), 9980-9991 (2014-10-10) Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells.Xu Li et al.Cancer letters, 357(1), 219-230 (2014-12-03) Effect of Smad3/4 on chemotherapeutic drug sensitivity in colorectal cancer cells.Sung Ung Moon et al.Oncology reports, 33(1), 185-192 (2014-11-06) [A case of advanced rectal cancer treated with leucovorin, fluorouracil, and oxaliplatin plus panitumumab preoperative chemotherapy].Hidenori Takahashi et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(12), 1953-1955 (2014-01-08) Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.Michael I DʼAngelica et al.Annals of surgery, 261(2), 353-360 (2014-03-22) A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma.Eileen M OʼReilly et al.Annals of surgery, 260(1), 142-148 (2014-06-06) Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.G Morris-Stiff et al.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 40(8), 1016-1020 (2013-12-29) Sensitization to oxaliplatin in HCT116 and HT29 cell lines by metformin and ribavirin and differences in response to mitochondrial glutaminase inhibition.Silvina M Richard et al.Journal of cancer research and therapeutics, 11(2), 336-340 (2015-07-08) The circadian rest-activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy.Elisabet Ortiz-Tudela et al.International journal of cancer, 134(11), 2717-2725 (2014-02-11) Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links.Akshada Sawant et al.DNA repair, 35, 126-136 (2015-11-01) Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I study.L B J van Iersel et al.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 40(11), 1557-1563 (2014-08-16) The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.Kali Janes et al.The Journal of biological chemistry, 289(30), 21082-21097 (2014-05-31) Population pharmacokinetic analysis of oxaliplatin in adults and children identifies important covariates for dosing.Mina Nikanjam et al.Cancer chemotherapy and pharmacology, 75(3), 495-503 (2015-01-06) Oxaliplatin salvage for recurrent ovarian cancer: a single institution's experience in patient populations with platinum resistant disease or a history of platinum hypersensitivity.Sarah E Taylor et al.Gynecologic oncology, 134(1), 68-72 (2014-04-29) Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.Karim Fizazi et al.The Lancet. Oncology, 15(13), 1442-1450 (2014-12-03) Defining the role of MRP-mediated efflux and glutathione in detoxification of oxaliplatin.C Mohn et al.Die Pharmazie, 68(7), 622-627 (2013-08-09) Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.Noriho Iida et al.Science (New York, N.Y.), 342(6161), 967-970 (2013-11-23) Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 study.Emmanouil Fokas et al.International journal of radiation oncology, biology, physics, 87(5), 992-999 (2013-11-12) New therapeutic possibilities of combined treatment of radiotherapy with oxaliplatin and its liposomal formulation, Lipoxal™, in rectal cancer using xenograft in nude mice.Thititip Tippayamontri et al.Anticancer research, 34(10), 5303-5312 (2014-10-03) A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration.A J M Beijers et al.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 22(7), 1999-2007 (2014-04-15) The Inhibition by Oxaliplatin, a Platinum-Based Anti-Neoplastic Agent, of the Activity of Intermediate-Conductance Ca²⁺-Activated K⁺ Channels in Human Glioma Cells.Mei-Han Huang et al.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 37(4), 1390-1406 (2015-10-22) Optimizing neoadjuvant therapy for rectal cancer with oxaliplatin.Ludmila Katherine Martin et al.Journal of the National Comprehensive Cancer Network : JNCCN, 11(3), 298-307 (2013-03-15) Phase II clinical trial of oxaliplatin and bevacizumab in refractory germ cell tumors.Amit Jain et al.American journal of clinical oncology, 37(5), 450-453 (2013-02-08) A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.Jorge Barbazán et al.International journal of cancer, 135(11), 2633-2643 (2014-04-23) USP38 regulates the stemness and chemoresistance of human colorectal cancer via regulation of HDAC3.Wei Zhan et al.Oncogenesis, 9(5), 48-48 (2020-05-15) RAS mutations and cetuximab in locally advanced rectal cancer: results of the EXPERT-C trial.F Sclafani et al.European journal of cancer (Oxford, England : 1990), 50(8), 1430-1436 (2014-03-04) Infusion of calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in colorectal cancer: a systematic review and meta-analysis.Zhenjie Wu et al.European journal of cancer (Oxford, England : 1990), 48(12), 1791-1798 (2012-05-01) Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility StudyVotanopoulos KI, et al. Annals of Surgical Oncology, 1-9 (2018) Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation.Dalia K Zaafar et al.PloS one, 9(6), e100562-e100562 (2014-06-28) Aqueous extract of Glycyrrhiza inflata inhibits aggregation by upregulating PPARGC1A and NFE2L2-ARE pathways in cell models of spinocerebellar ataxia 3.Chiung-Mei Chen et al.Free radical biology & medicine, 71, 339-350 (2014-03-29) A retrospective analysis of the risk factors for allergic reactions induced by the administration of oxaliplatin.H Yamauchi et al.European journal of cancer care, 24(1), 111-116 (2013-12-07) Clinical outcomes of reintroducing oxaliplatin to patients with colorectal cancer after mild hypersensitivity reactions.Sun Jin Park et al.Oncology, 85(6), 323-327 (2013-11-20) Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer.X Wang et al.British journal of cancer, 111(10), 1965-1976 (2014-10-17) Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970.Amy B Hall et al.Oncotarget, 5(14), 5674-5685 (2014-07-11) Deregulation of the PP2A inhibitor SET shows promising therapeutic implications and determines poor clinical outcome in patients with metastatic colorectal cancer.Ion Cristóbal et al.Clinical cancer research : an official journal of the American Association for Cancer Research, 21(2), 347-356 (2014-11-13) A phase 3 non-inferiority study of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study.Hirofumi Yasui et al.Journal of cancer research and clinical oncology, 141(1), 153-160 (2014-08-12) SUMOylation alterations are associated with multidrug resistance in hepatocellular carcinomaQin Y, et al. Molecular Medicine Reports, 9(3), 877-881 (2014) Intrathoracic anastomotic leakage after gastroesophageal cancer resection is associated with increased risk of recurrence.Steen C Kofoed et al.The Journal of thoracic and cardiovascular surgery, 150(1), 42-48 (2015-05-20) Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer.Ramchandra Vigay Amnekar et al.World journal of gastroenterology, 26(6), 598-613 (2020-02-28) Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models.S Cao et al.British journal of cancer, 110(7), 1733-1743 (2014-03-13) Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance).Deirdre R Pachman et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33(30), 3416-3422 (2015-08-19) Platinum-RNA modifications following drug treatment in S. cerevisiae identified by click chemistry and enzymatic mapping.Maire F Osborn et al.ACS chemical biology, 9(10), 2404-2411 (2014-07-24) Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis.Jui-Ho Wang et al.World journal of gastroenterology, 18(38), 5427-5433 (2012-10-20) Multiparametric Cell Cycle Analysis Using the Operetta High-Content Imager and Harmony Software with PhenoLOGIC.Andrew J Massey PloS one, 10(7), e0134306-e0134306 (2015-07-29) Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).Charles L Loprinzi et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(10), 997-1005 (2013-12-04) Targeted agents and oxaliplatin-containing regimens for the treatment of colon cancer.Andrea Bonetti et al.Anticancer research, 34(1), 423-434 (2014-01-10) Chemotherapy-induced peripheral neuropathy: the end of the beginning?Arun V Krishnan et al.Journal of neurology, neurosurgery, and psychiatry, 85(4), 359-359 (2013-07-09) Role of gap junction intercellular communication in testicular leydig cell apoptosis induced by oxaliplatin via the mitochondrial pathway.Xuhui Tong et al.Oncology reports, 33(1), 207-214 (2014-10-31) Effective Inhibition of Bone Morphogenetic Protein Function by Highly Specific Llama-Derived Antibodies.Silvia Calpe et al.Molecular cancer therapeutics, 14(11), 2527-2540 (2015-09-10) Navigating later lines of treatment for advanced colorectal cancer - optimizing targeted biological therapies to improve outcomes.Sharlene Gill et al.Cancer treatment reviews, 40(10), 1171-1181 (2014-12-03) Increased in vitro and in vivo sensitivity of BRCA2-associated pancreatic cancer to the poly(ADP-ribose) polymerase-1/2 inhibitor BMN 673.Alexandra-Zoe Andrei et al.Cancer letters, 364(1), 8-16 (2015-04-14) Study of Malformin C, a Fungal Source Cyclic Pentapeptide, as an Anti-Cancer Drug.Jing Wang et al.PloS one, 10(11), e0140069-e0140069 (2015-11-06) Periostin induces chemoresistance in colon cancer cells through activation of the PI3K/Akt/survivin pathway.Zhi-ming Xiao et al.Biotechnology and applied biochemistry, 62(3), 401-406 (2014-01-01) Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.Edward A Levine et al.Journal of the American College of Surgeons, 218(4), 573-585 (2014-02-05) Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.Ying Guo et al.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 22(5), 1223-1231 (2013-12-24) Metastatic colorectal cancer: current state and future directions.Marwan G Fakih Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33(16), 1809-1824 (2015-04-29) Randomized phase 2 trial of S1 and oxaliplatin-based chemoradiotherapy with or without induction chemotherapy for esophageal cancer.Dok Hyun Yoon et al.International journal of radiation oncology, biology, physics, 91(3), 489-496 (2015-02-15) Development of a Colorectal Cancer 3D Micro-tumor Construct Platform From Cell Lines and Patient Tumor Biospecimens for Standard-of-Care and Experimental Drug Screening.Steven Forsythe et al.Annals of biomedical engineering, 48(3), 940-952 (2019-04-26) A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer.Stefano Guadagni et al.International journal of molecular sciences, 21(13) (2020-07-11) Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: a prospective study of 216 patients.G Passot et al.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 40(5), 529-535 (2013-12-29) Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for the treatment of advanced intrahepatic cholangiocarcinoma.Guo-Wei Yang et al.OncoTargets and therapy, 8, 1245-1250 (2015-06-11) A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors.Autumn J McRee et al.Cancer chemotherapy and pharmacology, 74(1), 117-123 (2014-05-14) MRI-detectable polymeric micelles incorporating platinum anticancer drugs enhance survival in an advanced hepatocellular carcinoma model.Nguyen Quoc Vinh et al.International journal of nanomedicine, 10, 4137-4147 (2015-07-24) Regression of liver metastases after treatment with oxaliplatin/capecitabine and development of a progressive multifocal leukoencephalopathy in a patient with advanced thymoma.Annkristin Heine et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(12), e203-e205 (2013-03-20) The search for treatments to reduce chemotherapy-induced peripheral neuropathy.Deirdre R Pachman et al.The Journal of clinical investigation, 124(1), 72-74 (2013-12-21) Quantitative analysis of intraneuronal transport in human iPS neurons.Haruko Nakamura et al.Journal of pharmacological sciences, 128(4), 170-178 (2015-08-04) [Tolerance and efficacy of preoperative radiation therapy for elderly patients treated for rectal cancer].E Le Fur et al.Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 17(3), 202-207 (2013-05-07) Usefulness of circulating tumor cells after preliminary chemotherapy for prediction of response to further anticancer therapy in patients with initially unresectable metastatic colorectal cancer.Kai Neki et al.Anticancer research, 33(4), 1769-1772 (2013-04-09) Modulation of signaling enhances the efficacy of the combination of satraplatin and erlotinib.Abolfazl Avan et al.Current drug targets, 15(14), 1312-1321 (2014-11-11) BRG1 promotes chemoresistance of pancreatic cancer cells through crosstalking with Akt signalling.Xiaoran Liu et al.European journal of cancer (Oxford, England : 1990), 50(13), 2251-2262 (2014-06-24) Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part via microRNA-107.Rongyue Teng et al.PloS one, 10(12), e0143716-e0143716 (2015-12-05) Comparative Study of 17-AAG and NVP-AUY922 in Pancreatic and Colorectal Cancer Cells: Are There Common Determinants of Sensitivity?Leticia Mayor-López et al.Translational oncology, 7(5), 590-604 (2014-11-13) [Study of S-1 and oxaliplatin(SOX) plus bevacizumab as first-line therapy in patients with unresectable colorectal cancer].Hirotoshi Maruo et al.Gan to kagaku ryoho. Cancer & chemotherapy, 41(13), 2583-2586 (2015-01-18) Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines.Hyun-Hye Moon et al.Oncology reports, 35(1), 298-306 (2015-10-27) The MUC1 oncomucin regulates pancreatic cancer cell biological properties and chemoresistance. Implication of p42-44 MAPK, Akt, Bcl-2 and MMP13 pathways.Solange Tréhoux et al.Biochemical and biophysical research communications, 456(3), 757-762 (2014-12-17) A 21-year-old patient with a HER2-positive colorectal cancer.Frederike Bensch et al.Gastroenterology, 148(1), 20-21 (2014-12-03) The anti-tumor efficacy of 2-deoxyglucose and D-allose are enhanced with p38 inhibition in pancreatic and ovarian cell lines.Scott W Malm et al.Journal of experimental & clinical cancer research : CR, 34, 31-31 (2015-04-19) Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.M Peeters et al.European journal of cancer (Oxford, England : 1990), 51(13), 1704-1713 (2015-06-08) Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study.Stefano Guadagni et al.Journal of cancer research and clinical oncology, 146(5), 1273-1290 (2020-02-24) Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer.A F Hezel et al.British journal of cancer, 111(3), 430-436 (2014-06-25) Spongean alkaloids protect rat kidney cells against cisplatin-induced cytotoxicity.Florian Funk et al.Anti-cancer drugs, 25(8), 917-929 (2014-05-14) Risk factors for bowel dysfunction after sphincter-preserving rectal cancer surgery: a prospective study using the Memorial Sloan Kettering Cancer Center bowel function instrument.Myong Hoon Ihn et al.Diseases of the colon and rectum, 57(8), 958-966 (2014-07-09) PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.Alba Ginés et al.PloS one, 10(5), e0123830-e0123830 (2015-05-09) Anti-cancer applications of titanocene-functionalised nanostructured systems: an insight into cell death mechanisms.Jesús Ceballos-Torres et al.Chemistry (Weinheim an der Bergstrasse, Germany), 20(34), 10811-10828 (2014-04-10) [A case of portal hypertension after 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) chemotherapy].Hiroaki Ogata et al.Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 110(12), 2119-2126 (2013-12-07) GSK3A is redundant with GSK3B in modulating drug resistance and chemotherapy-induced necroptosis.Emanuela Grassilli et al.PloS one, 9(7), e100947-e100947 (2014-07-02) Successful treatment of recurrent metastatic nasopharyngeal carcinoma with oxaliplatin and doxorubicin.Rajkumar Venkatramani et al.Journal of pediatric hematology/oncology, 36(5), e307-e309 (2013-11-28) [Efficacy of oxaliplatin-based chemotherapy in Stage IV colorectal cancer patients with peritoneal carcinomatosis].Satoshi Hatano et al.Gan to kagaku ryoho. Cancer & chemotherapy, 40(12), 1981-1983 (2014-01-08) Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.Murray J Cutler et al.BMC cancer, 15, 882-882 (2015-11-11) Extravasation of oxaliplatin into the mediastinum: a case report and review of the literature.Roberto A Leon-Ferre et al.Clinical advances in hematology & oncology : H&O, 10(8), 546-548 (2012-10-18) Evaluation of melphalan, oxaliplatin, and paclitaxel in colon, liver, and gastric cancer cell lines in a short-term exposure model of chemosaturation therapy by percutaneous hepatic perfusion.Rajneesh P Uzgare et al.Anticancer research, 33(5), 1989-2000 (2013-05-07) Endostar in combination with modified FOLFOX6 as an initial therapy in advanced colorectal cancer patients: a phase I clinical trial.Zhiyu Chen et al.Cancer chemotherapy and pharmacology, 75(3), 547-557 (2015-01-13) Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors.Catherine G Lam et al.Journal of pediatric hematology/oncology, 37(1), e13-e18 (2014-06-20) Precision oncotherapy based on liquid biopsies in multidisciplinary treatment of unresectable recurrent rectal cancer: a retrospective cohort study.Stefano Guadagni et al.Journal of cancer research and clinical oncology, 146(1), 205-219 (2019-10-18) Oxaliplatin-induced neurotoxicity is mediated through gap junction channels and hemichannels and can be prevented by octanol.Alexia Kagiava et al.Neuropharmacology, 97, 289-305 (2015-06-06) Mapping the Human Kinome in Response to DNA Damage.Michel Owusu et al.Cell reports, 26(3), 555-563 (2019-01-17) Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.Konstantinos I Votanopoulos et al.Annals of surgical oncology, 26(1), 139-147 (2018-11-11) MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.Lucio Tentori et al.Cancer chemotherapy and pharmacology, 72(1), 117-125 (2013-05-03) Patterns of practice in the radiation therapy management of rectal cancer: survey of the Interregional Group Piedmont, Valle d'Aosta and Liguria of the "Associazione Italiana di Radioterapia Oncologica (AIRO)".Milena Di Genesio Pagliuca et al.Tumori, 99(1), 61-67 (2013-04-04) Association between GSTP1 Ile105Val polymorphism and oxaliplatin-induced neuropathy: a systematic review and meta-analysis.Zhi Peng et al.Cancer chemotherapy and pharmacology, 72(2), 305-314 (2013-05-23) Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma.Xi-Nan Shi et al.Molecular medicine reports, 12(5), 6501-6508 (2015-09-24) Efficacy and safety of capecitabine as maintenance treatment after first-line chemotherapy using oxaliplatin and capecitabine in advanced gastric adenocarcinoma patients: a prospective observation.Miao-zhen Qiu et al.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 35(5), 4369-4375 (2014-02-12) [A case of disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation caused by advanced colon cancer successfully treated with SOX/bevacizumab].Hiroaki Suzuki et al.Gan to kagaku ryoho. Cancer & chemotherapy, 41(8), 1013-1016 (2014-08-19) Bleeding from gastrointestinal tract recurrence of non-seminomatous germ cell tumour testis, showing temporary response to gemcitabine and oxaliplatin chemotherapy.Stephanie K Prince et al.The New Zealand medical journal, 126(1385), 76-80 (2013-11-13) Elevated serum IL-22 levels correlate with chemoresistant condition of colorectal cancer.Tingyu Wu et al.Clinical immunology (Orlando, Fla.), 147(1), 38-39 (2013-03-19) Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles.Khine Myint et al.PloS one, 10(7), e0130727-e0130727 (2015-07-02) Chk1 inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers.Christopher Bryant et al.BMC cancer, 14, 570-570 (2014-08-12) Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU/LV) and FU/LV plus oxaliplatin.Greg Yothers et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(36), 4512-4519 (2013-11-14) Oxaliplatin vs. cisplatin: competition experiments on their binding to lysozyme.Daniela Marasco et al.Dalton transactions (Cambridge, England : 2003), 44(22), 10392-10398 (2015-05-15) Epigenetic inactivation of the BRCA1 interactor SRBC and resistance to oxaliplatin in colorectal cancer.Catia Moutinho et al.Journal of the National Cancer Institute, 106(1), djt322-djt322 (2013-11-26) Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: A pain mechanism mediated by Pannexin 1.Lorenzo Di Cesare Mannelli et al.Neuropharmacology, 97, 133-141 (2015-06-14) Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir.Romain Coriat et al.The Journal of clinical investigation, 124(1), 262-272 (2013-12-21) Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17.S Y Brulé et al.European journal of cancer (Oxford, England : 1990), 51(11), 1405-1414 (2015-05-17) Anti-allodynic effects of obtusifolin and gluco-obtusifolin against inflammatory and neuropathic pain.Zhi-Wei He et al.Biological & pharmaceutical bulletin, 37(10), 1606-1616 (2014-07-30) Two cases of rupture of esophagogastric varices during the course of oxaliplatin-based chemotherapy for colorectal cancer.Ryuta Shigefuku et al.Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 111(12), 2326-2336 (2014-12-09) Circadian Clock Gene CRY2 Degradation Is Involved in Chemoresistance of Colorectal Cancer.Lekun Fang et al.Molecular cancer therapeutics, 14(6), 1476-1487 (2015-04-10) Study of diffusive- and convective-transport mediated microtumor growth in a controlled microchamber.Yu-Hsiang Hsu et al.Biomedical microdevices, 21(1), 7-7 (2019-01-05) Genetic polymorphisms associated with oxaliplatin-induced peripheral neurotoxicity in Japanese patients with colorectal cancer.Tomoyo Oguri et al.International journal of clinical pharmacology and therapeutics, 51(6), 475-481 (2013-04-04) Genetic variants in the glutathione S-transferase genes and survival in colorectal cancer patients after chemotherapy and differences according to treatment with oxaliplatin.Elisabeth J Kap et al.Pharmacogenetics and genomics, 24(7), 340-347 (2014-05-21) Retrospective evaluation of the efficacy of first-line treatment of advanced gastric cancer with docetaxel and oxaliplatin.Zhi-yuan Mao et al.Cancer investigation, 33(1), 16-21 (2014-12-17) Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double‑blind, placebo‑controlled trial of goshajinkigan to prevent oxaliplatin‑induced neuropathy.Toru Kono et al.Cancer chemotherapy and pharmacology, 72(6), 1283-1290 (2013-10-15)

Remarks